The Role of Platelet-Activating Factor in the Haemoincompatibility of Haemodialytic Treatments

Churchill D.N. . Efficiency and biocompatibility of membranes. In: Bonomini V. , Berland Y. , eds. Dialysis membranes: structure and predictions. Contrib Nephrology 1994; 113: 60–71.

Tetta C. , David S. , Biancone L. , Canino F. , Cambi V. , Camussi G. . Role of platelet activating factor in hemodialysis. Kidney Int 1993; 43(suppl. 39): 5154–7.

Chenoweth D.E. . Anaphylatoxin formation in extracorporeal circuits. Complement 1986; 3: 162–5.

Aljama P. . Biocompabilidad. Nefrologia 1990; X(3) 18–22.

Kazatchkine M.D. , Carreno M.P. . Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 1988; 9: 30–5.

Serhan C.N. , Haeggstrom J.Z. , Leslie C.C. . Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 1996; 10(10): 1147–58.

Pinckard R.N. , McManus L. , Hanahan D.J. . Chemistry and bio-logy of acetyl glyceryl ether phosphorylcholine (platelet-activating factor). Adv Inflammation Rev 1982; 4: 147.

Venable M.E. , Zimmerman G.A. , McIntyre T.M. , Prescott S.M. Platelet-activating factor: a phospholipid autcoid with diverse actions. J Lipid Res 1993; 34: 691.

Camussi G. , Tetta C. , Baglioni C. . The role of platelet-activating factor in inflammation. Clin Immun Immunopathol 1990; 57: 331.

Yue T.L. , Rabinovici R. , Feuerstein G. . Platelet-activating factor (PAF), a putative mediator in inflammatory tissue injury. Adv Exp Med Biol 1991; 314: 223.

McManus L.M. , Woodard D.S. , Deavers S.I. , Pinckard R.N. . PAF Molecular heterogeneity: pathobiological implications. Lab Invest 1993; 69: 639.

Bratton D. , Henson P.M. . Cellular origin of PAF. In: Platelet-activating factor and human Diseases. Barnes P.J. , Page C.P. , Henson P.M. , eds. London: Blackwell Scientific Publications, 1989; 23.

Camussi G. , Aglietta M. , Malavasi F. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983; 131: 2397.

Prescott S.M. , Zimmerman G.A. , Mcintyre T.M. . Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci USA 1984; 81: 3534.

Mcintyre T.M. , Zimmerman G.A. , Satoh K. , Prescott S.M. . Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest 1985; 76: 271.

Camussi G. , Tetta C. , Bussolino F. , Baglioni C. . Synthesis and release of platelet-activating factor is inhibited by plasma otiproteinase inhibitor or α-antichymotrypsin and is stimulated by proteinases. J Exp Med 1988; 1681: 293.

Montrucchio G. , Bergerone S. , Bussolino F. Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. Circulation 1993; 88: 1476.

Nakamura M. , Honda Z.I. , Izumi T. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991; 266: 20400.

Ye P.D. , Prossitz E.R. , Zuo A. , Cochrane C.G. . Characterization of a human cDNA that encodes a functional receptor for platelet-activating factor. Biochem Biophys Res Commun 1991; 180: 105.

Camussi G. , Montrucchio G. , Lupia E. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol 1995; 154: 6492–501.

Camussi G. , Turello E. , Bussolino F. , Baglioni C. . Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int Arch Allergy Appl Immunol 1991; 96: 84.

Alonso F. , Garcia Gil M. , Sanchez-Crespo M. , Mato J M. . Activation of l-alkyl-2-lysoglycerol-3-phosphocholine. Acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes. J Biol Chem 1982; 257: 3376–8.

Ninio E. , Mencia-Huerta I.M. , Heymans F. , Benveniste I. . Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. Biochim Biophys Acta 1982; 710: 23–31.

Lee T.C. , Leniham D.I. , Malone B. , Roddy L.L. , Wasserman S.I. . Increased biosynthesis of platelet activating factor in activated human eosinophils. J Biol Chem 1984; 259: 5526–30.

Pirotzky E. , Ninio E. , Bidault J. , Pflster A. , Benveniste J. . Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells. Lab Invest 1984; 51: 567–72.

Tetta C. , Camussi G. , Bussolino F. , Baglioni C. . Regulation of platelet activating factor synthesis by acetyl Coenzyme A. J Lipid Med 1990; 2: S55–S63.

Ninio E. , Breton M. , Bidault J. , Colard O. . Biosynthesis of pafacether. XVII Regulation by the CoA-independent transacylase in human neutrophils. FEBS Lett 1991; 289: 138–40.

Uemura Y. , Lee T. , Snyder F. . A COA-independent transacylase is linked to the formation of PAF by generating lyso-PAF intermediate in the remodelling pathway. J Biol Chem 1991; 266: 8268–72.

Venable M.E. , Nieto M. , Schmit J.D. , Wykle R. . Conversion of [3H]alkyl-AA-GropCho to lysoPAF by the CoA-independent transacylase in membrane fractions of neutrophils. J Biol Chem 1991; 266: 18691–8.

Colard O. , Bidault J. , Breton M. , Ninjo E. . Biosynthesis of platelet-activating factor in cultured mast cells. Involvement of the CoA-independent transacylase demonstrated by analysis of the molecular species of platelet-activating factor. Eur J Biochem 1993; 216: 835–840.

Renooij W. , Snyder F. . Biosynthesis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various tissues, Biochim Biophys Acta 1981; 663: 545–56.

Bussolino F. , Gremo F. , Tetta C. , Pescarmona G.P. , Camussi G. . Production of platelet activating factor by chick retina. J Biol Chem 1986; 261: 16502–16508.

Snyder F. . Platelet-activating factor and related lipid mediators. 1987; New York: Plenum Press, 471.

Lee T.C. , Malone B. , Snyder F. . A de novo pathway for the formation of 1-alkyl-2-acetyl-sn-glycerols, precursors of platelet activating factor. Biochemical characterisation of l-alkyl-2-l-so-sn-glyce-ro-3 -P: acetylcoA acetyltransferase in rat spleen. J Biol Chem 1986; 261: 5373–7.

Lee T.C. , Malone B. , Snyder F. . Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens. J Biol Chem 1988; 263: 1755–60.

McManus L.M. , Woodard D.S. , Deavers S.I. , Pinckard R.N. . PAF molecular heterogeneity: pathobiological implications. Lab Invest 1993; 69: 639–50.

Hanahan D.J. , Demopoulos C.A. , Liher J. , Pinckard R.N. . Identification of platelet-activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J Biol Chem 1980; 255: 5514–6.

Muller H.W. , O'Flaherty J.T. , Wykle R.L. . The molecular species distribution of platelet-activating factor synthesized by rabbit and human neutrophils. J Biol Chem 1984; 259: 14554–9.

Tokumura A. , Takauchi K. , Asai T. , Kamiyasu K. , Ogawa T. , Tsukatani H. . Novel molecular analogues of phosphatidylcholines in a lipid extract from bovine brain: 1-long-chain acyl-2-short chain acyl-sn-glycero-3-phoshocho lines. Lipid Res 1989; 30: 219–24.

Triggiani M. , Schlemmer R.P. , Warner J.A. , Chilton F.H. . Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by human inflammatory cells. J Immunol 1991; 146: 660–9.

Tessner T.G. , Wykle R.L. . Stimulated neutrophils produce ethanolamine plasmalogen analog of platelet-activating factor. J Biol Chem 1987; 262: 12660–4.

Farr R.S. , Cox C.P. , Wardlow M.L. , Jorgensen R. . Preliminary studies of an acid-labile factor (ALE) in human sera that inactivates platelet-activating factor (PAF). Clin Immunol Immunopathol 1980; 15: 318–330.

Blank M.L. , Lee T.C. , Fitzgerald V. , Snyder F. . A specific acetylhydrolase for I-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet activating lipid). J Biol Chem 1981; 256: 175–8.

Mahiout A. , Courtney J.M. . Effect of dialyser membranes on extracellular and intracellular granulocyte and monocyte activation in ex vivo pyrogen-free conditions. Biomaterials 1994; 15(12): 969.

Haeffner-Cavaillon N. , Cavaillon I.M. , Ciancioni C. , Bade F. , Delous S. , Kazatchine M.D. . In vitro induction of interleukin-1 during hemodialysis. Kidney Int 1989; 35: 121–1218.

Tetta C. , Segoloni G. , Turello E. . The production of cytokines in hemodialysis. Blood Purif 1990; 8: 337–46.

Bingel M. , Lonnemann G. , Koch K.M. , Dinarello C.A. , Shaldon S. . Plasma interleukin-1 activity during hemodialysis: the influences of dialysis membranes. Nephron 1988; 50: 273–82.

Herbelin A. , Nguyen A.T. , Zingraffj , Urena P. , Descamps-Latscha B. . Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor-α. Kidney Int 1990; 37: 116–25.

Herbelin A. , Urena P. , Nguyen A.T. , Zingraff J. , Descamps-Latscha B. . Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 1991; 39: 954–60.

Luger A. , Kovanik J. , Stunmavoll H.K. , Urbanska A. , Luger T. . Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 1987; 32: 84–8.

Blumenstein M. , Schmidt B. , Ward R.A. , Ziegler-Heitbrock H.W.L. , Gurland H.J. . Altered interleukin-1 production in patients undergoing hemodialysis. Nephron 1988; 50: 277–81.

Chollet-Martin S. , Stamatakis G. , Bailly S. , Mery J.P. , Gougerot P. , Acidalo M.A. . Induction of tumor necrosis factor-α during hemodialysis: influence of the membrane type. Clin Exp Inmunol 1991; 83: 329–32.

Pertosa O. , Marfella C. , Tarantino EA. Involvement of peripheral blood monocytes in haemodialysis: in-vivo induction of tumor necrosis factor alpha, interleukin-6, and β2-microglobulin. Nephrol Dial Transplant 1991; 2: 18–23.

Schindler R. , Lonnemann G. , Shaldon S. , Koch K.M. , Dinarello C.A. . Transcription, not synthesis of interleukin-l and tumor necrosis factor by complement. Kidney Int 1990; 37: 85–93.

David S. , Tetta C. , Camussi G. Adherence of human monocytes to haemodialysis membranes. Nephrol Dial Transplant 1993; 8: 1223–7.

Tetta C. , Tropea F. , Camussi G. Adherence of human monocytes to haemodialysis membranes: LFA 1 (CD11Ia/CD18) CR1 (CD35) and CI3 (CD11b/CD18) triggering promotes the biosynthesis of platelet-activating factor and adherence. Nephrol Dial Transplant 1995; 10: 1181–7.

Tetta C. , Segoloni G. , Pacitti A. , Camussi G. , Vercellone A. . The production of platelet-activating factor in hemodialysis. Int J Artif Organs 1989; 12: 766.

Cristol J.P. , Canaud B. , Damon M. , Chavis C. , Arnoux B. , Mion C. . Platelet-activating factor production during hemodialysis: effect of BN 5202 1. Prostaglandins-Leukot-Essent. Fatty Acids 1992; 45: 37–42.

Guastoni C. , Tetta C. , Hoenich N.A. Mechanisms and kinetics of the synthesis and releae of platelet-activating factor by polyacrylonitrile membranes. Clin Nephrol 1996; 46: 132–8.

Ronco C. , Tetta C. , Lupi A. Removal of platelet-activating factor in experimental continuous artero-venous hemofiltration. Crit Care Med 1995; 23: 99–107.